Us Pharma Market
- All
- News
- Videos
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Trump's 50% Tariff On Copper, 200% Pharma Warning: How It Impacts India
US President Donald Trump has announced new 50 per cent tariffs on copper, after having implemented similar duties on steel and aluminium imports.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Bharat Biotech Partners With US University For Single-Dose Covid Vaccine
Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...
-
Trading Calls: Buy Ashok Leyland, Aurobindo Pharma, Says Expert
Shares in the other Asian markets traded with a cautious mood as investors braced for an event-packed week headlined by US inflation data and the first House testimony by the new head of the Federal Reserve.
-
Pfizer Gets Pneumonia Vaccine Patent In Blow To Aid Group
It's a big victory for the US drugmaker in a market that has the world's largest number of pneumonia cases.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Trump's 50% Tariff On Copper, 200% Pharma Warning: How It Impacts India
US President Donald Trump has announced new 50 per cent tariffs on copper, after having implemented similar duties on steel and aluminium imports.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Bharat Biotech Partners With US University For Single-Dose Covid Vaccine
Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...
-
Trading Calls: Buy Ashok Leyland, Aurobindo Pharma, Says Expert
Shares in the other Asian markets traded with a cautious mood as investors braced for an event-packed week headlined by US inflation data and the first House testimony by the new head of the Federal Reserve.
-
Pfizer Gets Pneumonia Vaccine Patent In Blow To Aid Group
It's a big victory for the US drugmaker in a market that has the world's largest number of pneumonia cases.
